Alvit LCS Pharma News
4 articlesAlvit: Europe's search for cannabis flowers comes to an end
Cannabis-based products in a language doctors understand
growth-positive
Alvit LCS Pharma Sponsors Cannabis Pavilion in Davos
Alvit LCS Pharma, a medical cannabis company, is a sponsor of Cannatechs Canada Cannabis House in Davos. The CEO presented at the event and expressed the companys commitment to nurturing key relationships and showcasing their products and technologies. The Canada Cannabis House pavilion includes notable presenters and attendees from the cannabis industry. Alvit LCS Pharma specializes in pharma grade products and drug delivery technologies, with a focus on standardized cannabis extracts that have undergone clinical trials. The company aims to provide doctors with the knowledge they need to effectively prescribe cannabis to patients.
PartnersCustomers
growth-positive
Alvit LCS Pharma: Manufacturing and Licensing Agreement With Israel's Largest Medical Cannabis Company Bazelet
Bazelet, Israels largest Medical Cannabis Company, has signed a manufacturing and licensing agreement with Alvit LCS Pharma to manufacture, market, and sell Alvits line of pharma grade medical cannabis products in Israel and the EU. Bazelet will also collaborate with Alvit on the research and development of a new pharmaceutical drug for the treatment of Inflammatory Bowel Disease (IBD). This partnership strengthens Bazelets position in the Israeli Medical Cannabis market and expands its product offerings. Bazelets CEO, Meir Ariel, expressed excitement about the agreement and the potential benefits for patients. Alvit, an international leader in the development of products based on standardized cannabis extracts, will work with Bazelet to manufacture and distribute their products and develop an IBD product based on Bazelets unique API.
Partners
